These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35096589)

  • 1. The Role of Lymph Node Dissection for Non-Metastatic Renal Cell Carcinoma: An Updated Systematic Review and Meta-Analysis.
    Shi X; Feng D; Li D; Zhang F; Wei W
    Front Oncol; 2021; 11():790381. PubMed ID: 35096589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of lymph node dissection in patients undergoing radical nephrectomy for non-metastatic renal cell carcinoma: a systematic review and meta-analysis.
    Luo X; Li JX; Liu YT; Zou G; Yao WX; Qing GQ; Yang RL; Ye XY; Facchini G; Rossetti S
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6079-6090. PubMed ID: 31364109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta-analysis.
    Bhindi B; Wallis CJD; Boorjian SA; Thompson RH; Farrell A; Kim SP; Karam JA; Capitanio U; Golijanin D; Leibovich BC; Gershman B
    BJU Int; 2018 May; 121(5):684-698. PubMed ID: 29319926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse Effect of Lymph Node Dissection in Metastatic Renal Cell Cancer Patients Treated with Cytoreductive Nephrectomy: A Contemporary Analysis of Survival.
    Cao D; Huang Y; Zhang C; Wu J; Yu L; Zhang H; Shi G; Ye D
    J Cancer; 2019; 10(19):4639-4646. PubMed ID: 31528228
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymph node dissection in renal cell carcinoma.
    Capitanio U; Becker F; Blute ML; Mulders P; Patard JJ; Russo P; Studer UE; Van Poppel H
    Eur Urol; 2011 Dec; 60(6):1212-20. PubMed ID: 21940096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node dissection for upper tract urothelial carcinoma: A systematic review.
    Chan VW; Wong CHM; Yuan Y; Teoh JY
    Arab J Urol; 2020 Jul; 19(1):37-45. PubMed ID: 33763247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data.
    Sun M; Trinh QD; Bianchi M; Hansen J; Abdollah F; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    BJU Int; 2014 Jan; 113(1):36-42. PubMed ID: 23490031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection.
    Faiena I; Salmasi A; Lenis AT; Donin NM; Johnson DC; Bachour K; Drakaki A; Belldegrun AS; Pantuck AJ; Chamie K
    Urol Oncol; 2018 Feb; 36(2):79.e19-79.e26. PubMed ID: 29103965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
    Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
    BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of routine lymph node dissection alongside resection of intrahepatic cholangiocarcinoma: Systematic review and meta-analysis.
    Atif M; Borakati A; Mavroeidis VK
    World J Gastrointest Oncol; 2023 Nov; 15(11):2017-2032. PubMed ID: 38077644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emulating Target Clinical Trials of Radical Nephrectomy With or Without Lymph Node Dissection for Renal Cell Carcinoma.
    Bacic J; Liu T; Thompson RH; Boorjian SA; Leibovich BC; Golijanin D; Gershman B
    Urology; 2020 Jun; 140():98-106. PubMed ID: 32142726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical Nephrectomy with or without Lymph Node Dissection for pT3 Renal Cell Carcinoma: A Propensity Score-based Analysis.
    Li P; Peng C; Gu L; Xie Y; Nie W; Zhang Y; Xuan Y; Shen D; Du S; Tang L; Yao Y; Fan Y; Ma X; Zhang X
    J Cancer; 2019; 10(10):2369-2375. PubMed ID: 31258740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).
    Tilki D; Chandrasekar T; Capitanio U; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Linares Espinós E; Lorentz A; Martinez-Salamanca JI; Master VA; McKiernan JM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Rodriguez-Faba O; Russo P; Scherr DS; Shariat SF; Spahn M; Terrone C; Vera-Donoso C; Zigeuner R; Libertino JA; Evans CP
    Urol Oncol; 2018 Feb; 36(2):79.e11-79.e17. PubMed ID: 29129353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Current Role of Lymph Node Dissection in Nonmetastatic Localized Renal Cell Carcinoma.
    Ngai M; Chandrasekar T; Bratslavsky G; Goldberg H
    J Clin Med; 2023 May; 12(11):. PubMed ID: 37297925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma.
    Bekema HJ; MacLennan S; Imamura M; Lam TB; Stewart F; Scott N; MacLennan G; McClinton S; Griffiths TR; Skolarikos A; MacLennan SJ; Sylvester R; Ljungberg B; N'Dow J
    Eur Urol; 2013 Nov; 64(5):799-810. PubMed ID: 23643550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis.
    Gershman B; Thompson RH; Moreira DM; Boorjian SA; Tollefson MK; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Apr; 71(4):560-567. PubMed ID: 27671144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer.
    Dominguez-Escrig JL; Peyronnet B; Seisen T; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Gontero P; Lam T; MacLennan S; Mostafid H; Palou J; van Rhijn BWG; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
    Eur Urol Focus; 2019 Mar; 5(2):224-241. PubMed ID: 29158169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent of lymph node dissection improves overall survival in pT3N0 non-metastatic renal cell carcinoma patients treated with radical nephrectomy: a propensity score-based analysis.
    Wei Y; Wang M; Jin Y; Zhou C; Lyu J
    World J Urol; 2020 Jun; 38(6):1579-1585. PubMed ID: 31065795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European temporal trends in the use of lymph node dissection in patients with renal cancer.
    Capitanio U; Stewart GD; Larcher A; Ouzaid I; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Salagierski M; Volpe A; Mir MC; Kriegmair M; Terrone C; Brookman-May SD; Montorsi F; Klatte T;
    Eur J Surg Oncol; 2017 Nov; 43(11):2184-2192. PubMed ID: 28801061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends and outcomes of lymphadenectomy for nonmetastatic renal cell carcinoma: A propensity score-weighted analysis of the National Cancer Database.
    Farber NJ; Rivera-Núñez Z; Kim S; Shinder B; Radadia K; Sterling J; Modi PK; Goyal S; Parikh R; Mayer TM; Weiss RE; Kim IY; Elsamra SE; Jang TL; Singer EA
    Urol Oncol; 2019 Jan; 37(1):26-32. PubMed ID: 30446458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.